Why Amazon's RxPass is a bigger deal that you think

South Africa News News

Why Amazon's RxPass is a bigger deal that you think
South Africa Latest News,South Africa Headlines
  • 📰 axios
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 63%

While the response to RxPass was underwhelming, it was a 'tricky, good move,' according to Betsy Stanley, senior director at business strategy consultancy firm for Pinkston Strategy.

, allowing members access to unlimited prescriptions for generics for more than 80 conditions for $5 a month.Combined with its purchase of Amazon's One Medical last year, "it makes clear that the tech juggernaut intends to build a serious healthcare vertical," per the WSJ's David Wainer.

"Amazon has proven time and again it is willing to bleed cash on various ventures as a way to build overall engagement with Prime," he wrote.Mark Cuban's Cost Plus Drug Co., which is using a different strategy to drive down prices by offering a transparent pricing scheme.by removing pharmacy benefit managers from the supply chain or manufacturing the drugs on their own.

Amazon further expands its share of the consumer wallet and gets new data on their purchases, Stanley said. It could also set up direct competition with specialty brands like Hims and Ro by selling generic Viagra, she said. "I think RxPass is more of a stepping stone into normalizing Amazon's brand into health care," Stanley said. "Compared to previous efforts Amazon made in health care, this is getting a reaction of 'This just makes sense. This doesn't feel like a big deal' ... We're all normalizing health care and Amazon."

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

axios /  🏆 302. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WSJ News Exclusive | CVS Nearing $10.5 Billion Deal for Primary-Care Provider Oak Street HealthWSJ News Exclusive | CVS Nearing $10.5 Billion Deal for Primary-Care Provider Oak Street HealthCVS is nearing a $10.5 billion deal to acquire primary-care provider Oak Street Health, people familiar with the matter say
Read more »

CVS nearing $10.5 bln deal for primary-care provider Oak Street Health - WSJCVS nearing $10.5 bln deal for primary-care provider Oak Street Health - WSJCVS Health Corp is close to an agreement to buy primary care center operator Oak Street Health Inc for about $10.5 billion including debt, the Wall Street Journal reported on Monday, citing people familiar with the matter.
Read more »

WSJ News Exclusive | Bed Bath & Beyond Strikes Investor Deal for Over $1 Billion to Avoid BankruptcyWSJ News Exclusive | Bed Bath & Beyond Strikes Investor Deal for Over $1 Billion to Avoid BankruptcyThe distressed retailer has secured investor backing for a more than $1 billion capital raise to stave off bankruptcy and try to turn around its flagging business, people familiar with the matter said.
Read more »

WSJ News Exclusive | Apollo in Talks to Take Stake in CS First Boston SpinoffWSJ News Exclusive | Apollo in Talks to Take Stake in CS First Boston SpinoffAn investment in CS First Boston would represent another level of commitment from Apollo, which had previously agreed to take over Credit Suisse’s securitized-products group.
Read more »

WSJ News Exclusive | China Has More ICBM Launchers Than U.S., American Military ReportsWSJ News Exclusive | China Has More ICBM Launchers Than U.S., American Military ReportsThe U.S. military has notified Congress that China now has more land-based intercontinental-range missile launchers than the U.S., fueling the debate about how Washington should respond to Beijing’s nuclear buildup.
Read more »



Render Time: 2025-02-28 00:36:55